Rosiglitazone reverses endothelial dysfunction but not remodeling of femoral artery in Zucker diabetic fatty rats

Rosiglitazone reverses endothelial dysfunction but not remodeling of femoral artery in Zucker diabetic fatty rats

<p>Abstract</p> <p>Objectives</p> <p>Endothelial dysfunction precedes atherogenesis and clinical complications in type 2 diabetes. The vascular dysfunction in Zucker diabetic fatty (ZDF) rats was evaluated at different ages along with the effect of treatment with rosigl...

Full description

Bibliographic Details
Main Authors: Onyia Jude E, Zimmerman Karen M, Karathanasis Sotirios K, Guo Xiaomei, Lu Xiao, Peterson Richard G, Kassab Ghassan S
Format: Article
Language:English
Published: BMC 2010-05-01
Series:Cardiovascular Diabetology
Online Access:http://www.cardiab.com/content/9/1/19

Internet

http://www.cardiab.com/content/9/1/19

Similar Items